Mon, May 4, 2026
May 4
exercised or converted securities in COAG
64,680 shares @ $0.00
Decreased holdings by -100.00%
Net across this filing: +69.10% (+2,551,518 shares)
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
COAGHemab Therapeutics Holdings, Inc.
ManufacturingBiological Products, (No Diagnostic Substances)
1D0.00%
1W-8.27%
1M+3.91%
3M+76.58%
6M—
1Y—
Recent insider activity at COAG
Jun 16Ra Capital Management, L.p.Bought$1.54mJun 15Ra Capital Healthcare Fund LpBought$152.97kMay 20Ra Capital Management, L.p.Bought$24.84kMay 19Ra Capital Management, L.p.Bought$94.94kMay 12Ra Capital Management, L.p.Bought$159.04kMay 11Rajeev M. ShahBought$346.23kMay 11Peter KolchinskyBought$643.00kMay 8Peter KolchinskyBought$37.05k